Cargando…

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer

Detalles Bibliográficos
Autores principales:	Jeong, Seung-hwan, Kwak, Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422000/ https://www.ncbi.nlm.nih.gov/pubmed/34488249 http://dx.doi.org/10.4111/icu.20210275

Ejemplares similares

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
por: Lee, Hak Jong, et al.
Publicado: (2016)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
por: Song, Byeongdo, et al.
Publicado: (2023)

The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
por: Franzese, Elisena, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting (68)Ga-NGUL PET/CT in Healthy Volunteers and Patients with Prostate Cancer
por: Suh, Minseok, et al.
Publicado: (2022)

Prostate-specific antigen screening for prostate cancer: An old but never-ending story
por: Kim, Sun Il
Publicado: (2023)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Immunotherapy for prostate cancer: Requirements for a successful regime transfer
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
por: Liberini, Virginia, et al.
Publicado: (2022)

Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen
por: Lee, Dong Kil, et al.
Publicado: (2010)

In Search of a New Prostate-Specific Antigen
por: Kim, Jin Wook
Publicado: (2019)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)

Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
por: Rosenfeld, Lior, et al.
Publicado: (2020)

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
por: Paschalis, Alec, et al.
Publicado: (2019)

Male health: is prostate specific antigen alone useful?
Publicado: (2023)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
por: Cho, Hee Ju, et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2014)

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
por: Dassie, Justin P, et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
por: Sheehan, Beshara, et al.
Publicado: (2022)

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen-Based Therapeutics
por: Akhtar, Naveed H., et al.
Publicado: (2012)

Incidental prostate-specific membrane antigen-avid meningioma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2021)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2022)

Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer
por: Unger, Clara, et al.
Publicado: (2022)

Editorial Comment: (68)Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis
por: Zequi, Stênio de C.
Publicado: (2021)

Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane
por: Godeiro, Katyanne Dantas, et al.
Publicado: (2006)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
por: Wang, Xinning, et al.
Publicado: (2021)

(64)Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells
por: Sommer, Ulrich, et al.
Publicado: (2022)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Jayaraj, Rama, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dbd6akt4fnfclmj6tfkve566c5